EUVIMEDObjevte EUVIMED
Open access

Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development

Julien Smith-Roberge iD, Farinaz Forouzannia iD, Abdullah Hamadeh iD, Zeny Feng iD, Nashira Popovic iD, William W L Wong iD

JMIR Public Health and Surveillance · 2025

DOI: 10.2196/66309 ↗

At a glance

Journal article in JMIR Public Health and Surveillance, 2025. Written by Julien Smith-Roberge and 5 co-authors. Institution: School of Pharmacy, University of Waterloo, 10A Victoria St. S., Kitchener, ON, N2G 1C5, Canada, 1 519-888-4567 ext 21323. Major MEDLINE topics: Hepatitis B, Chronic. 24 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Chronic hepatitis B (CHB) remains a significant health burden for at least a hundred thousand Canadians. The government of Canada has endorsed the global strategy to eliminate hepatitis as a public health threat by 2030, but effectively targeting public health interventions is complicated by the silent nature of the disease, which can remain asymptomatic for decades.

Objective

This study develops a framework to estimate the prevalence of CHB and the proportion of the infected population that remains undiagnosed. We apply the proposed method to national data from Canada, from 2007 to 2021.

Methods

We infer the prevalence and undiagnosed proportion of CHB by fitting a mathematical state-transition model, based on the natural history of CHB, to observed CHB-related events. Data for the calibration were obtained from the Public Health Agency of Canada and Statistics Canada.

Results

We estimate the national prevalence of CHB in Canada in 2021 to be 0.483% (95% CI 0.443%-0.535%). The corresponding percentage of undiagnosed cases was estimated to be 54.3% (95% CI 50.9%-58.9%).

Conclusions

The estimates of CHB prevalence obtained via our method are in line with previous estimates obtained from national seroprevalence studies. More specialized estimates, stratified by province or age cohort, may be achievable with detailed health administrative data.

Subjects

MeSH terms (MEDLINE)

Hepatitis B, ChronicHumansCanadaPrevalenceAdultMiddle AgedFemaleMaleAdolescentAgedModels, TheoreticalChild

Author keywords

CHBCanadachronic hepatitis Bdecompensated cirrhosisdiagnosisestimateestimateshepatitishepatitis Bhepatocellular carcinomaliverliver transplantmathematical frameworkmathematical modelingprediction

Authors and institutions

  • School of Pharmacy, University of Waterloo, 10A Victoria St. S., Kitchener, ON, N2G 1C5, Canada, 1 519-888-4567 ext 21323.
  • Department of Mathematics and Statistics, University of Guelph, Guelph, ON, Canada.
  • Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON, Canada.

ORCID profiles: Julien Smith-Roberge, Farinaz Forouzannia, Abdullah Hamadeh, Zeny Feng, Nashira Popovic, William W L Wong

Cite

APA

Smith-Roberge, J., Forouzannia, F., Hamadeh, A., Feng, Z., Popovic, N., & Wong, W. W. L. (2025). Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development. JMIR Public Health and Surveillance. https://doi.org/10.2196/66309

Vancouver

Smith-Roberge J, Forouzannia F, Hamadeh A, Feng Z, Popovic N, Wong WWL. Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development. JMIR Public Health and Surveillance. 2025. doi:10.2196/66309

BibTeX
@article{SmithRoberge2025,
  author = {Smith-Roberge, Julien and Forouzannia, Farinaz and Hamadeh, Abdullah and Feng, Zeny and Popovic, Nashira and Wong, William W L},
  title = {Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development},
  journal = {JMIR Public Health and Surveillance},
  year = {2025},
  doi = {10.2196/66309}
}
Start for free →